Larimar Therapeutics Inc (LRMR) Historical Volatility

Tracking LRMR historical volatility helps you see how much Larimar Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Larimar Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor LRMR 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The LRMR 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Larimar Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Larimar Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where LRMR HV is running hot, cold, or in line. Make the LRMR 30 day historical volatility — and every other window — work for your edge instead of against it.